Microviable Therapeutics welcomes Ana Sañudo, PhD on board. With a BSc degree in Biotechnology at the University of Leon (2009) and PhD at the University of Granada (2016), Ana has worked more than ten years testing probiotics functionality and bioactive compounds across diverse companies and research centers. Additionally, she has participated in novel probiotics development, from strain discovery to clinical trials studies. She joined Microviable Therapeutics in 2022 as a research scientist with the aim of supporting the R&D area.
Looking forward to complete a great team!